Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Protocol ID
ANHL1931
Disease (Sub Disease)
Lymphoma
Diagnosis Stage
Newly Diagnosed
Location
NSW, QLD, VIC
Sponsor
National Cancer Institute (NCI)
Collaborators
Children's Oncology Group
Trial Status
Open
Sites
John Hunter Children's Hospital
The Children's Hospital at Westmead
Queensland Children's Hospital
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
2 Years and older
International registry ID's
NCT04759586
Back to Registry
Study Title A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Protocol ID ANHL1931
Disease (Sub Disease) Lymphoma
Diagnosis Stage Newly Diagnosed
Location NSW / QLD / VIC
Sponsor National Cancer Institute (NCI)
Collaborators Children's Oncology Group
Links https://clinicaltrials.gov/ct2/show/NCT04759586
Trial Status Open
Trial Open Date 07/06/2021
Sites John Hunter Children's Hospital/ The Children's Hospital at Westmead/ Queensland Children's Hospital / Royal Children's Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility 2 Years and older
International registry ID's NCT04759586